Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesic effect of HuLisan after total knee arthroplasty
ChiCTR2400081975Phase 4Not yet recruiting
- Sponsor
- Xi'an Honghui Hospital
- Start
- Mar 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of hulisan in knee osteoarthritis (OA) (2 arms), sponsored by Xi'an Honghui Hospital. Primary endpoint: Pain score (VAS). Planned start Mar 2024; status: not yet recruiting.
02
Drugs
hulisan
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2400081975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081975.